Pages that link to "Q29615944"
Jump to navigation
Jump to search
The following pages link to Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics (Q29615944):
Displaying 50 items.
- Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer (Q21090542) (← links)
- Hallmarks of Cancer: The Next Generation (Q22252312) (← links)
- The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase (Q24294745) (← links)
- Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 (Q24304533) (← links)
- Transcriptional regulation of BRCA1 expression by a metabolic switch (Q24307973) (← links)
- A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression (Q24322269) (← links)
- Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1 (Q24337524) (← links)
- Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1 (Q24338684) (← links)
- Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells (Q24613508) (← links)
- HIF-1: upstream and downstream of cancer metabolism (Q24647482) (← links)
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy (Q26740191) (← links)
- Blue-Print Autophagy: Potential for Cancer Treatment (Q26741800) (← links)
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis (Q26744233) (← links)
- Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications (Q26747274) (← links)
- Hypoxic control of metastasis (Q26749159) (← links)
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment (Q26749571) (← links)
- Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma (Q26752515) (← links)
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance (Q26765869) (← links)
- p73: a Positive or Negative Regulator of Angiogenesis, or Both? (Q26771853) (← links)
- Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy (Q26778008) (← links)
- Exploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish models (Q26778116) (← links)
- Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance (Q26779535) (← links)
- Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication (Q26795759) (← links)
- Progress toward overcoming hypoxia-induced resistance to solid tumor therapy (Q26796405) (← links)
- Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date (Q26822717) (← links)
- Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution? (Q26824421) (← links)
- Is cancer a metabolic disease? (Q26852241) (← links)
- Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? (Q26852282) (← links)
- Role of hypoxia-inducible factors in breast cancer metastasis (Q26860122) (← links)
- HypoxamiRs and cancer: from biology to targeted therapy (Q26863298) (← links)
- Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis (Q26866144) (← links)
- Hypoxia-mediated regulation of macrophage functions in pathophysiology (Q26992189) (← links)
- Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy (Q27012888) (← links)
- Hypoxia-inducible factors in physiology and medicine (Q27013770) (← links)
- Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate (Q27021794) (← links)
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression (Q27025886) (← links)
- Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents (Q27318801) (← links)
- Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. (Q27319546) (← links)
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases (Q27667409) (← links)
- Structure-Based Design of Covalent Siah Inhibitors (Q27679208) (← links)
- Hypoxia: an alarm signal during intestinal inflammation (Q27691319) (← links)
- Structural integration in hypoxia-inducible factors (Q27701731) (← links)
- The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy (Q28067724) (← links)
- Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer (Q28075965) (← links)
- In vitro models of cancer stem cells and clinical applications (Q28076101) (← links)
- Implications of Hypoxia in Breast Cancer Metastasis to Bone (Q28077444) (← links)
- Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet (Q28079816) (← links)
- Adipose tissue dysfunction and its effects on tumor metabolism (Q28080748) (← links)
- Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment (Q28081657) (← links)